Kieren Marr

Executive Officer, Director at Pearl Diagnostics.

Raised on Pearl Diagnostics filings

$11.2M

of $11.2M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Apr 21, 2026

Company

Pearl Diagnostics

Biotech · Baltimore, MD

Urine tests for invasive fungal lung infections

Urine tests for invasive fungal lung infections

Investors: 21
Founded: 2022

Investors: 21
Sector: Biotech
Founded: 2022
HQ: Baltimore, MD

Pearl Diagnostics filings

Pearl Diagnostics Form D filings
Filed	Security	Sold of offered	Filing
Apr 21, 2026	Equity	$11.2M/ $11.2M	Form D

EquityFiled Apr 21, 2026Form D
$11.2M/ $11.2M

Works with

Also named on Pearl Diagnostics filings

Eric GornsteinChief Executive Officer, Form D signerForm D signer Brad SpellbergDirector John CammackDirector